René Patzwahl

  • Citations Per Year
Learn More
PURPOSE To evaluate serial apparent diffusion coefficient (ADC) measurements of bone metastases in prostate cancer to determine whether antiandrogen resistance can be detected and time to progression estimated. MATERIALS AND METHODS Diffusion-weighted imaging (DWI) was performed at 1.5T in nine patients with treatment-naïve metastatic prostate cancer (20(More)
Diffusion-weighted imaging quantified using the mono-exponential model has shown great promise for monitoring treatment response in prostate cancer bone metastases. The aim of this prospective study is to evaluate whether non-mono-exponential diffusion models better describe the water diffusion properties and may improve treatment response assessment.(More)
Can Diffusion-Weighted Imaging Detect Antihormonal Resistance in Patients with Prostate Cancer Bone Metastases? Carolin Reischauer, Johannes M. Froehlich, Dow-Mu Koh, René Patzwahl, Christoph A. Binkert, Sebastian Kos, and Andreas Gutzeit Institute of Radiology and Nuclear Medicine, Clinical Research Unit, Hirslanden Klinik St. Anna, Lucerne, Switzerland,(More)
  • 1